Another study found that people whose glucose levels put them at a more serious risk of cardiovascular failure or stroke do not reduce these risks when they take omega-3 unsaturated fatty acids.

The people studied, who were supported by a drug organisation, had type 2 diabetes or were at risk of developing it. The people who took 900 milligrams of omega-3 unsaturated fatty acids a day were no more uncertain over a six-year period about whether they had cardiovascular failure, had a stroke or bit the dust off you than the people who received the wrong treatment took everything into account.

Daily supplements “have not reduced the risk of cardiovascular events in patients at high risk of cardiovascular events,” analysts concluded in the study published online today (11 June) in the New England Journal of Medicine.

Previous epidemiological studies, in which analysts gathered information and looked for links between, for example, dietary preferences and well-being, recommended that people who routinely eat fish or take omega-3 supplements have a lower risk of heart disease. However, such studies only alluded to accessions; in order to obtain solid evidence of a medical benefit, specialists should make clinical preparations in which patients are randomly assigned to receive some form of therapy or participate in a benchmark group.

In the new Sanofi-funded study, which produces insulin infusions, specialists examined 12,500 people with type 2 diabetes, obstructed fasting glucose levels (with a view to testing glucose levels after a fasting period) or weakened glucose resistance (in light) to a test showing how well a person’s body can handle glucose after drinking a glucose supplement).

Throughout the duration of the study, 574 of the members taking the omega-3 supplement (9.1 percent) came out of a coronary episode or stroke, as did 581 of the members taking the counterfeit treatment tablets (9.3 percent).

In addition, 1,034 members who took the improvements (16.5 percent) had a heart attack or stroke, while 1,017 members (16.3 percent) received the wrong treatment.

Individuals taking the drugs saw a decrease in their fatty oil levels of 14.5 milligrams per deciliter in general, contrasted with members taking the wrong treatment.

The study was limited, the specialists noted, because the proportion of omega-3 used may have been too low to even consider promoting a medical benefit. This part was chosen on the grounds that previous tests had recommended that this level be considered helpful.

The results come from a comprehensive report written by specialists at the Population Health Research Institute in Hamilton, Ontario.

Share it with others: In people with type 2 diabetes or pre-diabetes, taking omega-3 unsaturated fats does not help prevent coronary failure or strokes, says another study.

Follow MyHealthNewsDaily on Twitter @MyHealth_MHND Discover us on Facebook.